Suppr超能文献

墨西哥裔美国老年人的空腹总同型半胱氨酸(tHcy)浓度与死亡率

Fasting total homocysteine (tHcy) concentration and mortality in older Mexican Americans.

作者信息

Colon Lopez V, Haan M N, Aiello A E, Ghosh D

机构信息

Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, MI, USA.

出版信息

J Nutr Health Aging. 2008 Dec;12(10):685-9. doi: 10.1007/BF03028615.

Abstract

OBJECTIVES

This study examines the association between tHcy on cardiovascular and noncardiovascular mortality.

DESIGN

Longitudinal study of 1,633 Mexican Americans age>60 years recruited in 1998.

SETTING

Sacramento, California.

MEASUREMENTS

Cox proportional models were used to estimate the effects of tHcy on mortality rate in the total sample and in a subgroup of subjects without a history of cardiovascular disease at baseline.

RESULTS

About half of the cohort was born in Mexico. Among Mexican-born participants, high tHcy (>11.0 micromol/L) was associated with a higher rate of cardiovascular mortality compared to those with low tHcy concentration<or=11.0 micromol/L (HR=2.74 95%CI [1.61, 4.66]). Among the US-born, higher tHcy predicted cardiovascular mortality (HR=1.74 95%CI [1.08, 2.82]). When the effects of tHcy were evaluated in the subgroup without self-report of cardiovascular disease at baseline, the effect of high tHcy on mortality remained only among the Mexican-born. These differences did not appear to be influenced by demographic, lifestyle factors, chronic diseases or biological markers at baseline. No significant associations between tHcy and noncardiovascular mortality were observed for either group.

CONCLUSIONS

The effect of tHcy on cardiovascular mortality is nearly 40% stronger among the immigrant group. tHcy might be an early marker of subclinical vascular pathology amongst the Mexican-born group, despite their apparently healthy profile at baseline.

摘要

目的

本研究探讨总同型半胱氨酸(tHcy)与心血管及非心血管疾病死亡率之间的关联。

设计

对1998年招募的1633名年龄大于60岁的墨西哥裔美国人进行纵向研究。

地点

加利福尼亚州萨克拉门托。

测量

采用Cox比例模型估计tHcy对总样本以及基线时无心血管疾病史的受试者亚组死亡率的影响。

结果

约一半的队列成员出生于墨西哥。在出生于墨西哥的参与者中,与tHcy浓度较低(≤11.0微摩尔/升)的人相比,高tHcy(>11.0微摩尔/升)与心血管死亡率较高相关(风险比[HR]=2.74,95%置信区间[CI][1.61, 4.66])。在美国出生的人中,较高的tHcy预示着心血管死亡率(HR=1.74,95%CI[1.08, 2.82])。当在基线时无心血管疾病自我报告的亚组中评估tHcy的影响时,高tHcy对死亡率的影响仅在出生于墨西哥的人中仍然存在。这些差异似乎不受基线时人口统计学、生活方式因素、慢性病或生物学标志物的影响。两组中均未观察到tHcy与非心血管疾病死亡率之间存在显著关联。

结论

在移民群体中,tHcy对心血管死亡率的影响要强近40%。尽管出生于墨西哥的人群在基线时表面上健康,但tHcy可能是该群体中亚临床血管病变的早期标志物。

相似文献

1
Fasting total homocysteine (tHcy) concentration and mortality in older Mexican Americans.
J Nutr Health Aging. 2008 Dec;12(10):685-9. doi: 10.1007/BF03028615.
7
Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
Eur J Prev Cardiol. 2012 Dec;19(6):1420-9. doi: 10.1177/1741826711424568. Epub 2011 Sep 29.
9
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.
Stroke. 2004 Oct;35(10):2263-9. doi: 10.1161/01.STR.0000142374.33919.92. Epub 2004 Sep 2.

引用本文的文献

1
Cystathionine β-synthase and methylenetetrahydrofolate reductase mutations in Mexican individuals with hyperhomocysteinemia.
SAGE Open Med. 2020 Nov 20;8:2050312120974193. doi: 10.1177/2050312120974193. eCollection 2020.

本文引用的文献

1
Lowering homocysteine for stroke prevention.
Lancet. 2007 Jun 2;369(9576):1841-1842. doi: 10.1016/S0140-6736(07)60830-7.
3
Improvement in stroke mortality in Canada and the United States, 1990 to 2002.
Circulation. 2006 Mar 14;113(10):1335-43. doi: 10.1161/CIRCULATIONAHA.105.570846.
4
Homocysteine lowering with folic acid and B vitamins in vascular disease.
N Engl J Med. 2006 Apr 13;354(15):1567-77. doi: 10.1056/NEJMoa060900. Epub 2006 Mar 12.
5
Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging.
Am J Clin Nutr. 2003 Sep;78(3):441-7. doi: 10.1093/ajcn/78.3.441.
6
Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.
J Am Geriatr Soc. 2003 Feb;51(2):169-77. doi: 10.1046/j.1532-5415.2003.51054.x.
7
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
BMJ. 2002 Nov 23;325(7374):1202. doi: 10.1136/bmj.325.7374.1202.
8
Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
Arch Intern Med. 2001 Nov 26;161(21):2628-9. doi: 10.1001/archinte.161.21.2628.
10
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
Arch Intern Med. 2001 Jul 9;161(13):1589-94. doi: 10.1001/archinte.161.13.1589.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验